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The NF-kB pathway plays important roles in immune
responses. Although its regulation has been exten-
sively studied, here, we report an unknown feedfor-
ward mechanism for the regulation of this pathway
by Toll-like receptor (TLR) ligands in macrophages.
During bacterial infections, TLR ligands upregulate
the expression of the 11S proteasome subunit
PSME3 via NF-kB-mediated transcription in macro-
phages. PSME3, in turn, enhances the transcriptional
activity of NF-kB by directly binding to and destabi-
lizing KLF2, a negative regulator of NF-kB transcrip-
tional activity. Consistent with this positive role of
PSME3 in NF-kB regulation and importance of the
NF-kB pathway in host defense against bacterial in-
fections, the lack of PSME3 in hematopoietic cells
renders the hosts more susceptible to bacterial
infections, accompanied by increased bacterial bur-
dens in host tissues. Thus, this study identifies a
substrate for PSME3 and elucidates a proteolysis-
dependent, but ubiquitin-independent, mechanism
for NF-kB regulation that is important for host de-
fense and innate immunity.
INTRODUCTION
Bacterial infections are still threatening public health worldwide,
even though various types of antibiotics are available (Scallan
et al., 2011). A better understanding of themechanisms by which
bacterial pathogens are sensed by host immune systems may
contribute to new approaches for developing antimicrobials.
Bacterial pathogens can elicit host responses by interacting
with cell-surface Toll-like pattern recognition receptors (CreaghCand O’Neill, 2006; Kawai and Akira, 2010; Kumar et al., 2009;
Skaug et al., 2009) to activate signaling pathways and gene tran-
scription of various proinflammatory cytokines, bactericidal
agents, and enzymes for protection of the hosts from pathogenic
infection (Kolls et al., 2008; Medzhitov and Horng, 2009). Tight
regulation of these key signaling pathways is essential for im-
mune system homeostasis. Otherwise, inappropriate activation
or overactivation of immune responses may result in inflamma-
tory disorders such as septic shock and autoimmunity (Gordon
and Martinez, 2010; Karin et al., 2006; Liew et al., 2005). Thus,
identification of the regulators that control the inflammatory re-
sponses is vital.
The protein degradation pathways have important roles in
bacterial infections, host defense, and immune responses
(Jiang and Chen, 2012). The degradation of cellular proteins
is mediated primarily by the ubiquitously expressed multi-sub-
unit proteasome, which is involved in the regulation of almost
every biological process, including the cell cycle, apoptosis,
development, and major histocompatibility complex class I
(MHC I) antigen presentation (Kloetzel, 2001; Rock et al.,
2002). The proteasome is composed of a 20S catalytic subunit
and one of three classes of regulatory subunits: 19S (PA700),
11S (PSME, PA28, or REG), and PA200 (Demartino and Gil-
lette, 2007; Lo¨we et al., 1995; Ustrell et al., 2002). The 26S
proteasome, composed of the 19S and 20S subunits, is
responsible for selective degradation of most intracellular
substrates in an ATP- and ubiquitin-dependent manner (Mur-
ata et al., 2009). The 11S-activated proteasome mediates
protein degradation in a ubiquitin- and ATP-independent
manner. Three members of the PSME family—PSME1-3
(a.k.a. PA28a, -b, and -g or REGa, -b, and -g)—have been
characterized. In contrast to PSME1 and PSME2, which form
hetero-oligomers, PSME3 forms a homo-oligomer (Dubiel
et al., 1992). In addition, PSME3 is found mainly in the nu-
cleus, whereas PSME1/2 is distributed throughout the cell
(Wo´jcik et al., 1998).ell Reports 14, 737–749, February 2, 2016 ª2016 The Authors 737
Myriad amount of evidence indicates that the ubiquitin-protea-
some pathway plays important roles in host defense (Sun, 2008).
However, the role of the PSME-proteasome pathway in the in-
flammatory response remains largely unknown. Previous studies
have shown that interferon g (IFNg)-inducible PSME1 and
PSME2 are part of the immunoproteasomes, which are involved
in the generation ofMHC-I-presented peptides, whereas PSME3
is not involved (Fr€uh and Yang, 1999; Rechsteiner et al., 2000;
Sun et al., 2002). PSME3-knockout (KO) mice have a smaller
body size (Murata et al., 1999). In agreement with this, growth ar-
rest and increased apoptosis are observed in mouse embryonic
fibroblasts (MEFs) (Mao et al., 2008; Murata et al., 1999; Re-
chsteiner and Hill, 2005). Furthermore, PSME3-KO mice show
slightly decreased numbers of CD8+ T cells and impaired clear-
ance of pulmonary fungal infections (Barton et al., 2004). PSME3
also speeds degradation of hepatitis C virus core protein and is
essential for the nuclear retention of the hepatitis C virus (HCV)
core protein (Moriishi et al., 2003). Increased class switching in
B cells can also be observed from PSME3-deficient mice, since
PSME3 can target nuclear AID for degradation (Uchimura et al.,
2011). However, the role of PSME3 in innate immunity and host
defense against infections by bacterial pathogens remains
unknown.
Lung Kr€uppel-like factor 2 (KLF2) (Anderson et al., 1995),
which belongs to the Kr€uppel-like factor (KLF) family of zinc-
finger transcription factors, has been implicated in the regulation
of many cellular processes, including T cell activation andmigra-
tion, atherosclerosis, and monocyte differentiation (Cao et al.,
2010; Carlson et al., 2006; Shaked and Ley, 2012). In myeloid
cells, KLF2 functions as a negative regulator of myeloid cell acti-
vation by suppressing the activation of the necrosis factor kB
(NF-kB) pathway and has an important role in the host response
to polymicrobial infections (Das et al., 2006; Mahabeleshwar
et al., 2011, 2012).
In this study, we identified KLF2 as a substrate for PSME3 and
characterized a feedforward mechanism for the regulation of the
NF-kB pathway in macrophages. In this mechanism, Toll-like re-
ceptor (TLR) ligands upregulate PSME3 expression via NF-kB,
and PSME3, in turn, enhances the transcriptional activity of
NF-kB through destabilizing KLF2. This mechanism has an
important role in host defense against bacterial infections.
RESULTS
Upregulation of PSME3 Expression by TLR Ligands
through NF-kB
Query of PSME3 in the gene expression database BioGPS
(http://www.biogps.org) revealed that the expression of
PSME3 is significantly upregulated in peripheral blood cells of
human patients with sepsis (Wong et al., 2009). We confirmed
these microarray results by quantitative real-time PCR analysis
of an independent group of patients with sepsis in comparison
to normal individuals (Figure 1A). This result raises a possibility
that PSME3 expression may be regulated by bacteria or TLR li-
gands. Indeed, the mRNA and protein levels of PSME3 signifi-
cantly increased in mouse peritoneal macrophages (PEMs)
treated with Escherichia coli (E. coli) (Figures 1B and 1C) or lipo-
polysaccharide (LPS) (Figures 1D and 1E). LPS could also stim-738 Cell Reports 14, 737–749, February 2, 2016 ª2016 The Authorsulate the expression of PSME3 in a mouse macrophage cell line
(RAW264.7) (Figures S1A and S1B). In addition to LPS, which ac-
tivates TLR4, ligands to other TLRs could also stimulate the
expression of PSME3 in PEMs (Figure 1F). Consistent with this
conclusion, Listeria monocytogenes (L. monocytogenes), which
primarily activates TLR2, could also upregulate PSME3 expres-
sion (Figures S1C and S1D).
Next, we investigated the mechanism by which PSME3
expression is regulated by TLR signaling. TLRs signal through
both NF-kB and MAPK (mitogen-activated protein kinase) path-
ways (Krachler et al., 2011; Neish and Naumann, 2011). There-
fore, we tested a number of MAPK and NF-kB inhibitors:
SP600125 (a JNK inhibitor), SB20358 (a p38 inhibitor), U0126
(a MEK inhibitor), BMS-345541, BAY-11-7082, and SN-50
(NF-kB inhibitors). We found that inhibition of NF-kB, but not of
MAPKs, impeded LPS-induced PSME3 upregulation in PEMs
(Figure 1G). Consistent with the pharmacological results, small
interfering RNA (siRNA)-mediated knockdown of p65, a key
NF-kB isoform inmacrophages (Li and Verma, 2002), in PEMs in-
hibited LPS-induced upregulation of PSME3 expression (Fig-
ure 1H). Furthermore, overexpression of IKKb, which activates
NF-kB signaling in 293T cells, could also increase PSME3
expression (Figure S1E). To determine whether PSME3 is a
direct target gene of NF-kB, we analyzed the PSME3 promoter
region using TFSEARCH software; we also used UCSC (Univer-
sity of California, Santa Cruz) Genome Bioinformatics and rVista
2.0 (Chan et al., 2010) and identified a potential NF-kB cis-
element sequence (GGAAAGCCCGGTGC). This sequence is
located at 1.3 kb upstream of the first exon of the PSME3 gene
(Figure 1I). A chromatin immunoprecipitation (ChIP) assay re-
vealed that p65, as well as its transcriptional coactivator p300,
bound to this NF-kB cis-element sequence in response to LPS
treatment (Figure 1J). Thus, these data, together with the results
that protein synthesis inhibitor cycloheximide (CHX) abrogated
LPS-induced upregulation of PSME3 protein (Figure S1F),
indicate that TLR ligands upregulate PSME3 expression via
NF-kB-mediated gene transcription.
Hematopoietic PSME3 Is Important for Host Defense
against Bacterial Infections
NF-kB signaling in macrophages plays important roles in host
defense against bacterial infections, including the L. monocyto-
genes infection (Rahman and McFadden, 2011). We used mice
receiving the transfer of either PSME3-KO or wild-type (WT)
bone marrow (BM) to assess the role of PSME3 in host defense
to the L. monocytogenes infection to avoid complications that
may result from PSME3 expression in non-hematopoietic cells.
The BM-transplanted mice were inoculated with a lethal dose
of L. monocytogenes, and those that received the PSME3-KO
BM were significantly more susceptible to L. monocytogenes-
induced lethality than those receiving the WT BM (Figure 2A).
Concordantly, PSME3-KO BM-transplanted mice showed a
greater loss of average body weight than that of WT BM-trans-
planted ones after L. monocytogenes infection (Figure 2B).
Next, we assessed the role of PSME3 in bacterial clearance.
The lack of PSME3 resulted in significantly higher bacterial loads
in the liver and spleen in mice inoculated with L. monocytogenes
(Figures 2C and 2D). We also examined the importance of
Figure 1. NF-kB Dependent Upregulation of PSME3 Expression
(A) The mRNA expression level of PSME3 in peripheral white blood cells from healthy human controls (HC) or patients with sepsis as determined by quantitative
real-time PCR. ***p < 0.001 (Student’s t test); n = 20.
(B and C) Effects of E. coli on PSME3 expression in PEMs. The mRNA (B) and protein (C) levels of PSME3 in PEMs incubated with E. coli were determined by
quantitative real-time PCR and western blot analysis, respectively. *p < 0.05 (Student’s t test).
(D and E) Effects of LPS on PSME3 expression in PEMs. The mRNA (D) and protein (E) levels of PSME3 in PEMs incubated with LPS were determined by
quantitative real-time PCR and western blot analysis, respectively. *p < 0.05 (Student’s t test).
(F) Effects of Pam3Csk4, poly(I:C), LPS, or CpG-ODN on PSME3 expression in PEMs. PEMs were treated with the ligands for 4 hr, and cell lysates were analyzed
for expression of PSME3 by immunoblotting. Ctrl, control.
(G) Effects of MAPK and NF-kB inhibitors on PSME3 expression in PEMs. PEMs were pretreated with or without the inhibitors for 2 hr before LPS treatment for
4 hr. Cell lysates were analyzed by immunoblotting.
(H) Effects of p65 knockdown on PSME3 expression in PEMs. PEMs were transfected with control siRNA or p65-specific siRNA for 72 hr and then treated with
LPS for 4 hr. Cell lysates were analyzed by immunoblotting.
(I) Schematic representation of the PSME3 promoter and the putative NF-kB cis-element sequence.
(J) Effect of LPS on binding of p65 and its coactivator to the cis-element on the PSME3 promoter. PEMs were treated with or without LPS, and a ChIP assay was
performed using an anti-p65 or anti-p300 antibody for immunoprecipitation (IP), followed by PCR with PSME3 promoter-specific primers.
Error bars indicate mean ± SD.
See also Figure S1.
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Figure 2. PSME3 Has an Important Role in Bacterial Clearance
(A andB)Mice lacking PSME3 in their hematopoietic cells aremore susceptible to L.monocytogenes infection.Micewere lethally irradiated and transplantedwith
either WT or PSME3-KO BM cells. Two months after transplantation, the mice were infected with L. monocytogenes (53 105 CFU per mouse). Their survival (A)
and body weight (B) were recorded.
(C and D) Effect of PSME3-deficiency on L. monocytogenes clearance. BM-transplanted mice were infected with L. monocytogenes, and the liver and spleen
were collected on day 3. The enumerations of bacterial CFUs were performed through the serial dilution plating assay. ***p < 0.001 (Student’s t test); n = 6.
(E–F) Effect of PSME3 deficiency on bacterial clearance in a CLP model. Sham or CLP procedure was performed on the BM-transplanted mice, and the blood,
lungs, livers, and kidneys were collected 12 hr later for assessment of bacterial loads. **p < 0.01 and ***p < 0.001 (Student’s t test); n = 6.PSME3 in bacterial clearance using a polymicrobial infection
model—the cecal ligation and puncture (CLP) model. The CLP
has been adopted to model human sepsis (Buras et al., 2005).
Enumeration of bacterial colonies from the blood and homoge-
nates of the liver, spleen, and lung revealed that the lack of
PSME3 in the hematopoietic cells resulted in significantly
increased numbers of colony-forming units (CFUs) (Figures
2E–2H) over the controls. All of the results together indicate
that PSME3 expression in hematopoietic cells plays an impor-
tant role in effective bacterial clearance and host defense against
bacterial infections.
PSME3 Deficiency Impairs Bactericidal Activities of
Macrophages
The defect in bacterial clearance can be caused by an impair-
ment of the bactericidal capability of macrophages. Therefore,
we examined the role of PSME3 in bacterial clearance bymacro-
phages using an in vitro assay—the antibiotic protection assay
(APA). In this assay, PEMs lacking PSME3 showed significant
impairment in bactericidal activity compared to the WT PEMs
(Figure 3A). Consistent with this observation, knockdown of the
endogenous PSME3 by its specific siRNA in RAW264.7 cells
also significantly attenuated bactericidal activity (Figure S2A).
Because PSME3 deficiency in PEMs or PSME3 knockdown in
RAW264.7 cells did not affect phagocytosis (Figures S2B and
S2C), we suspected that PSME3 deficiency may affect the740 Cell Reports 14, 737–749, February 2, 2016 ª2016 The Authorsexpression of antimicrobial substances by macrophages.
Indeed, PSME3-deficient macrophages expressed significantly
lower levels of CRAMP and iNOS mRNAs when they were stim-
ulated by L. monocytogenes, E. coli, or LPS (Figures 3B–3D).
Consistent with the reduction in the iNOSmRNA inmacrophages
lacking PSME3, PSME3 deficiency also reduced the iNOS pro-
tein levels and nitric oxide (NO) production in macrophages
upon LPS stimulation (Figures 3E and 3F). These observations
could also be recapitulated in RAW264.7 cells; knockdown of
PSME3 by its siRNA resulted in reduction in LPS-induced
expression of CRAMP and iNOS mRNAs and iNOS protein, as
well as production of NO (Figures S3A–S3D).
PSME3 Regulates the Assembly of NF-kB
Transcriptional Complex at Its Promoters
To understand how PSME3 regulates the expression of antimi-
crobial genes, we first examined whether PSME3 deficiency
affected LPS-stimulated MAPK and NF-kB signaling in macro-
phages, which regulates the expression of the iNOS andCRAMP
genes (Li et al., 2009; Rahman and McFadden, 2011). PSME3
deficiency did not significantly affect the phosphorylation levels
of JNK, ERK, and p38 in BM-derived macrophages (BMDMs)
stimulated with LPS (Figure 4A), nor did it affect the degradation
rate of IkBa (Figure 4A). PSME3 deficiency also did not exert a
noticeable effect on LPS-induced nuclear accumulation of the
NF-kB subunit p65 or its phosphorylation (Figures 4B–4D).
Figure 3. PSME3 Deficiency Impairs Bactericidal Activity of Macrophages
(A) Effect of PSME3 deficiency on bactericidal activity in vitro. PEMs were incubated with E. coli at an MOI of 4, and bacterial killing capability was analyzed by
APA. ***p < 0.001 (Student’s t test).
(B–D) Effect of PSME3 deficiency on LPS-induced expression of iNOS and CRAMP. PEMs were treated with L. monocytogenes (B), E. coli (C), or LPS (D) for 6 hr.
The relative mRNA levels of iNOS and CRAMP was determined by quantitative real-time PCR. *p < 0.05; **p < 0.01 (Student’s t test). Ctrl, control.
(E) Effect of PSME3 deficiency on the protein level of iNOS. PEMs were stimulated with LPS for indicated hours. Cell lysates were analyzed by immunoblotting.
(F) Effect of PSME3 deficiency on NO production. Conditioned media of LPS-treated PEMs were analyzed for nitrite by the Griess assay. ***p < 0.001 (Student’s
t test).
Error bars indicate mean ± SD.
See also Figures S2 and S3.These results suggest that PSME3 may not be involved in MAPK
and NF-kB signaling. Therefore, we examined the effect of
PSME3 on the binding of p65 to the promoters of its downstream
target genes using the ChIP assay. We found that the binding of
p65 to the iNOS, TNFa, IL1b, and CRAMP promoters was mark-
edly attenuated in PSME3-deficient macrophages (Figure 4E).
We also found that the binding of p300, a p65 coactivator that
is required for transcriptional activity of the NF-kB pathway, to
the iNOS, TNFa, IL1b, and CRAMP promoters was impaired in
PSME3-KO macrophages (Figure 4E). These data suggest that
PSME3 regulates the expression of NF-kB downstream target
genes by affecting the binding of NF-kB and its transcriptional
coactivator to its promoter, and this may be a general mecha-
nism for PSME3 to regulate of NF-kB-mediated transcription ofCits target genes. Supporting this hypothesis, PSME3 deficiency
in PEMs or PSME3 knockdown in RAW cells attenuated LPS-
induced expression of two other NF-kB target genes, IL-1b
and TNFa (Figure S4). Therefore, the data we have gathered
thus far indicate that PSME3, whose expression is upregulated
by the TLR ligands via the NF-kB pathway, facilitates NF-kB-
mediated transcriptional activity. In other words, PSME3 func-
tions in a positive feedforward mechanism for LPS-induced
NF-kB signaling.
PSME3 Promotes the Degradation of KLF2
To understand how PSME3 regulates NF-kB-mediated tran-
scriptional activity, we sought to identify binding partners or sub-
strates for PSME3 that may link PSME3 to the NF-kB pathway.ell Reports 14, 737–749, February 2, 2016 ª2016 The Authors 741
Figure 4. PSME3 Deficiency Inhibits the Binding of p65 and Its Transcriptional Coactivators to NF-kB Target Gene Promoters
(A) Effect of PSME3 deficiency on LPS-induced MAPK and NF-kB signaling. BMDMs were stimulated with LPS followed by western blotting analysis.
(B–D) Effect of PSME3 deficiency on LPS-induced p65 nuclear translocation and phosphorylation. BMDMs were stimulated with LPS. They were directly
analyzed by western blot for phosphorylated p65 (D), fractionated into the nuclear and cytosolic fractions followed by western blotting (B), or stained with an anti-
p65 antibody (green) followed by observation under a fluorescence microscope (C). Ctrl, control.
(E) Effect of PSME3 deficiency on LPS-induced binding of p65 and its coactivator to the promoters of NF-kBdownstream target genes. PEMswere treatedwith or
without LPS, and the ChIP assay was performed with an anti-p65, anti-p300, or IgG antibody for immunoprecipitation (IP), followed by PCRwith the iNOS, TNFa,
IL1b, CRAMP promoter-specific primers.
See also Figure S4.We immunoprecipitated PSME3 from H1299 cells expressing
Flag-tagged PSME3 and subjected precipitated proteins to
mass spectrometry (MS) analysis. Among the proteins identified742 Cell Reports 14, 737–749, February 2, 2016 ª2016 The Authorsby MS with high confidence, there was one known to be related
to NF-kB signaling, which is KLF2 (Figure S5A). KLF2 inhibits
NF-kB signaling by suppressing the binding of p65 coactivators
to the promoters of the NF-kB target genes (Das et al., 2006). We
subsequently confirmed the interaction of PSME3with KLF2, us-
ing both coimmunoprecipitation and pull-down assays (Figures
5A and 5B). We also found that PSME3 was colocalized with
KLF2 in the nuclei of co-transfected HeLa cells (Figure S5B)
and that endogenous PSME3 interacted with endogenous
KLF2 in PEMs (Figure 5C). Importantly, PSME3 could target
KLF2 for degradation, because expression of PSME3 reduced
the protein levels of coexpressed KLF2 in HEK293T cells (Fig-
ure 5D). By contrast, expression of the other PSME3 familymem-
bers (PSME1, PSME2, or PSME1/2) had no effect on the KLF2
protein level (Figure 5D). To determine whether KLF2 is directly
degraded by the PSME3 proteasome, we used a rabbit reticulo-
cyte-coupled transcription/translation system (Promega) to pro-
duce the KLF2 protein, and incubation of PSME3 and the 20S
proteasome resulted in the degradation of KLF2, suggesting
that KLF2 might be a direct substrate of PSME3 (Figure 5E).
Furthermore, the finding that PSME3 reduced the half-life of
KLF2 (Figures 5F and 5G) supports the idea that PSME3 regu-
lates the protein stability of KLF2, and the observation that
PSME3-mediated destabilization of KLF2 is sensitive to the
20S proteasome inhibitor MG132 (Figure S5C) further confirms
that the action of PSME3 is proteasome mediated. Next, we
found that the inactivated mutants of PSME3, including N151Y,
P245Y, and G105S, that failed to destabilize p21 as previously
reported (Chen et al., 2007; Li et al., 2007) also failed to destabi-
lize KLF2 (Figure 5H). Together with the observation that the
activated PSME3mutant K188D showed enhanced KLF2 degra-
dation (Figure 5H), we conclude that PSME3 most likely pro-
motes KLF2 destabilization via their direct interaction in a
proteasome activity-dependent manner.
Next, we examined the importance of endogenous PSME3 in
the stability of the KLF2 protein. Knockdown of PSME3
increased the half-life of the KLF2 protein in HeLa cells (Figures
5I and 5J). More importantly, the levels of endogenous KLF2 pro-
tein were higher in the PSME3 null PEMs than in the WT PEMs
(Figure 5K), whereas the mRNA levels of KLF2 were no different
in these cells (Figure S5D). The same results were observed in
PSME3 knockdown of RAW264.7 cells (Figures S5E and S5F).
In addition, the half-life of the KLF2 protein was increased in
the PSME3-deficient macrophages compared to that in the WT
cells (Figures 5L and 5M). Previous studies demonstrated that
three E3 ligases (FBW7, WWP1, and Smurf1) could target
KLF2 for degradation via the 26S proteasome (Wang et al.,
2013; Xie et al., 2011; Zhang et al., 2004). However, siRNA-medi-
ated depletion of FBW7, WWP1, or Smurf1 in HeLa cells did not
affect PSME-mediated degradation of KLF2 (Figures S5G–S5I),
suggesting that these E3 ligases may not be involved in the ac-
tion of PSME. Additionally, the KLF2 4A mutant, which is resis-
tant to FBW7-mediated degradation (Wang et al., 2013), could
still be degraded by PSME3 (Figures S5J and S5K). These results
together clearly support a conclusion that PSME3 directly tar-
gets KLF2 for degradation.
PSME3 Regulates Bactericidal Activities via KLF2
Consistent with the role of KLF2 in inhibiting NF-kB-dependent
gene expression (Mahabeleshwar et al., 2011), expression of
KLF2 markedly inhibited tumor necrosis factor a (TNFa) andCIKKb-activated NF-kB reporter gene activity (Figure 6A). Impor-
tantly, coexpression of WT PSME3, but not the N151Y mutant,
was able to reverse the inhibitory effect of KLF2, indicating that
PSME3 can regulate NF-kB transcriptional activity by relieving
KLF2-mediated inhibition (Figure 6A; Figure S6A). To determine
whether KLF2 is involved in the regulation of bactericidal activ-
ities by PSME3, peritoneal macrophages were transfected with
the siRNAs against PSME3 and/or KLF2, which worked effi-
ciently in these cells (Figure S6B). KLF2 depletion not only signif-
icantly enhanced the macrophages’ bactericidal activities as
previously reported (Mahabeleshwar et al., 2011) but also abro-
gated the inhibitory effect of PSME3 knockdown on bactericidal
activities (Figure 6B). The same results were observed for LPS-
induced NO production and expression of iNOS, IL-1b, and
TNFa; knockdown of KLF2 increased the production of NO
and expression of iNOS, IL-1b, and TNFa and abrogated the
effects of PSME3 knockdown (Figures 6C–6F). These results
support the conclusion that PSME3 regulates NF-kB and bacte-
ricidal activities in a largely KLF2-dependent manner.
DISCUSSION
In the present work, we describe a previously unknown positive
feedforward mechanism for the regulation of NF-kB by TLR li-
gands via the 11S proteasome regulatory subunit PSME3 (Fig-
ure 7). In this mechanism, PSME3 expression is upregulated
by TLR ligands via NF-kB, and PSME3, in turn, promotes
NF-kB transcriptional activity by destabilizing a NF-kB transcrip-
tional suppressor KLF2. Thismechanism has an important role in
effective clearance of bacterial infection in mice.
Studies have demonstrated that ubiquitination underlies
important mechanisms for the regulation of diverse immune
responses (Liu and Chen, 2011; Sun, 2008). A number of E3
ubiquitin ligases have been identified for their roles in immune
functions, including the development and activation of immune
cells, immune tolerance, and innate immune responses (Liu
and Chen, 2011; Sun, 2008). For example, ubiquitin-mediated
protein degradation and different types of polyubiquitin chains,
such as K63-linked ubiquitination, are involved in the activation
of NF-kB (Skaug et al., 2009; Wertz and Dixit, 2010). Our present
study provides an important insight into the role of the ubiquitin-
independent 11S proteasome subunit PSME3 in the regulation of
TLR-NF-kB signaling in macrophages and host defense against
bacterial infections. Of note, a recent report suggests that
PSME3 is downregulated in sepsis and negatively regulates
NF-kB signaling (Yan et al., 2014). The reason for the discrep-
ancies is unclear, which are likely due to the use of different tech-
niques, animal models, sample collections, and/or cell types. For
instance, Yan et al. relied solely on siRNA in their study of the
function of PSME3 in macrophages without rigorous controls
for possible ‘‘off-target’’ effects of this approach.
NF-kB represents a family of structurally related transcription
factors that are regulated by a wide range of extracellular stimuli.
They play pivotal roles in regulation of innate and adaptive im-
mune responses. TLR ligands are potent activators of the
NF-kB pathway. The core mechanism for this activation
centered on the IKK complex has been well understood. In
addition, NF-kB signaling is modulated by other regulations atell Reports 14, 737–749, February 2, 2016 ª2016 The Authors 743
Figure 5. PSME3 Binds to and Destabilizes KLF2
(A) Interaction of PSME3 with KLF2. GFP-PSME3 was cotransfected with an empty vector or Flag-KLF2 into 293T cells. The transfected cells were lysed after
treatment with MG132 for 6 hr, followed by immunoprecipitation with an anti-Flag antibody. The immunoprecipitates (IPs) and the original whole-cell extracts
(WCEs) were analyzed by immunoblotting.
(B) Direct interaction between PSME3 and KLF2. Purified GST-PSME3 protein was incubated with purified His-KLF2. After GST pull-down, proteins were
analyzed by immunoblotting.
(C) Interaction of endogenous proteins. BMDMswere stimulated with or without LPS for 4 hr, and immunoprecipitation was performedwith an anti-KLF2 antibody
or IgG control. The proteins were analyzed by immunoblotting.
(D) Effect of PSME3 expression on the protein levels of coexpressed HA-KLF2. HA-KLF2 was expressed in 293T cells with PSME1, PSME2, PSME3, or PSME1/2.
The KLF2 protein was detected by immunoblotting.
(E) KLF2 is is a direct substrate of PSME3. In vitro proteolytic analysis was performed using 10 ml purified KLF2, 0.25 mg purified 20S proteasome, and 1 mg PSME3
heptamers for the indicated times in 50 ml reaction volume at 30C. An aliquot of the reaction was analyzed by western blotting.
(F and G) Effect of PSME3 expression on the protein stability of coexpressed HA-KLF2. HA-KLF2 was coexpressed with PSME3 in 293T cells. The half-life of HA-
KLF2 was detected by the CHX chase assay.
(H) Effect of PSME3mutant expression on the protein levels of coexpressedHA-KLF2. HA-KLF2was coexpressedwith PSME3mutants including N151Y, P245Y,
G105S, and K188D in 293T cells.
(legend continued on next page)
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various steps of the pathway. KLF2 is a transcription regulator
that inhibits NF-kB transcriptional activity by directly binding to
the NF-kB transcriptional coactivator p300 (Ahmad and Lingrel,
2005; Das et al., 2006; Huddleson et al., 2005). KLF2 has been
shown to have functions in macrophages that are opposite to
what we have shown for PSME3 (Das et al., 2006; Mahabelesh-
war et al., 2011), which is consistent with the conclusion of this
study that PSME3 regulates macrophage functions by destabi-
lizing KLF2. Although both the protein level and the mRNA level
of KLF2 in macrophages decrease upon treatment of bacterial
products (Mahabeleshwar et al., 2012), the regulation of
KLF2 at the protein level in macrophage remains largely unchar-
acterized. Previously, we showed that the E3 ligase FBXW7 can
target KLF2 for degradation in endothelial cells through a mech-
anism that depends on GSK3-mediated phosphorylation of
KLF2 (Wang et al., 2013). In the present study, we demonstrated
that KLF2 stability is regulated by an ubiquitin-independent
mechanism via the 11S proteasome subunit PSME3 in macro-
phages. It remains to be determined whether KLF2 stability
can also be regulated by ubiquitin-dependent mechanisms in
macrophages.
PSME3 deficiency resulted in significant reductions in a
number of TLR-mediated transcriptional responses despite the
magnitudes of these reductions being modest, i.e., at about
50%. We believe the significant in vivo phenotypes in lethality
and bacterial burden are probably the results of summation of
these modest reductions. We postulate that this PSME3-medi-
ated positive feedforward mechanism may be needed by the
hosts to mount more effective defense against bacterial
infection. Although our present study focuses on the macro-
phages, it is possible that this feedforward mechanism plays
important roles in NF-kB signaling in other immune and non-
immune cells. Further investigation is warranted to investigate
this possibility.
EXPERIMENTAL PROCEDURES
Mice
Mice were purchased from the National Rodent Laboratory Animal Resources,
Shanghai Branch, and maintained in a laminar airflow cabinet under specific
pathogen-free conditions according to the NIH standards established in the
Guide for the Care and Use of Laboratory Animals. PSME3-KO mice were
described previously (Li et al., 2015). All the protocols were approved by
East China Normal University.
Cell Culture and Transfection
HEK293T cells, HeLa cells, and RAW264.7 cells were cultured in DMEM
supplemented with 10% fetal bovine serum (FBS) and penicillin-streptomycin.
To obtain BMDMs, BM cells were collected from mouse femurs and tibias
and cultured for 7 days in DMEM supplemented with 10% FBS, penicillin-
streptomycin, and 20% conditioned medium (a 7-day supernatant from an
L-929 cell line stably expressing macrophage colony-stimulating factor
[M-CSF]) (Lombardo et al., 2007). To isolate primary mouse peritoneal macro-(I and J) Effect of PSME3 knockdown on the protein levels of HA-KLF2. HA-KLF2
was assessed by the CHX chase assay.
(K) Effect of PSME3 deficiency on LPS-induced upregulation of the KLF2 protein le
immunoblotting.
(L and M) Effect of PSME3 deficiency on KLF2 protein stability. The KLF2 protein
See also Figure S5.
Cphages, mice were injected with 3% sterile thioglycollate (Sigma, 70157)
intraperitoneally (3 ml per mouse). Three days later, the mice were euthanized,
and RPMI medium was injected intraperitoneally and then retrieved. The cells
were then treated with ACK (ammonium-chloride-potassium) red blood cell
(RBC) lysis buffer (0.15 M NH4Cl, 10.0 mM KHCO3, and 0.1 mM EDTA) and
washed with PBS. The purity of the macrophages was confirmed by flow
cytometry.
Transfections were performed using calcium phosphate-DNA coprecipita-
tion (for 293T cells), Lipofectamine 2000 (for HeLa cells and PEMs; Invitrogen),
and FUGEN HD (for RAW264.7 cells; Roche) according to the manufacturers’
instructions and with the following siRNA sequences: PSME3, GAATCAA
TATGTCACTCTA; KLF2, GCAUGGAUGAGGACCUAAAUUTT.
BM Transplantation
BM cells were flushed from the tibias and femurs of C57BL/6 mice using RPMI
supplemented with 2% FBS and penicillin-streptomycin. After RBC lysis, the
cells were washed and resuspended in 1 ml PBS containing 107 cells, after
which 200 ml of BM cells was injected intravenously into lethally irradiated
(10 Gy) recipients.
CLP
All mice were maintained under specific pathogen-free conditions. C57BL/6
mice between 6 and 8 weeks old were given general anesthesia. A midline lap-
arotomy was performed, and the cecum was exteriorized, ligated, and punc-
tured twice with a 21-gauge needle. A small amount of the bowel contents was
extruded to ensure wound patency. The cecum was replaced in its original
location, and the abdomen was closed using a two-layer technique. Control
surgeries (sham) were performed in the same manner, but the cecum was
neither ligated nor punctured. The mice were resuscitated while under a
37C heating blanket. These mice were euthanized 12 hr after CLP, and their
blood, lung, liver, heart, and kidney tissues were isolated and homogenized.
Bacterial CFUs were enumerated by serial dilution and plated on soya agar
plates.
APA
Bacteria were grown to the logarithmic phase in Luria broth (LB) medium (for
E. coli) to an optical density at 600 nm (OD600)z 10
8 CFU/ml. These bacteria
were pelleted and washed with PBS and then resuspended and diluted to the
desired concentration in non-antibiotic-containing DMEM supplemented with
10%FBS. The bacteria were added tomonolayers of RAW264.7 cells or PEMs
at an MOI of four (for E. coli) bacteria per cell, and then the culture plates were
incubated for 2 hr at 37C after centrifugation at 500 3 g for 10 min. The cells
were washed three times with PBS and incubated with antibiotic-containing
media for 30 min to kill surface-associated bacteria. The macrophages were
cultured for an additional 4 hr and lysed with trypsin-EDTA and 0.025% Triton
X-100. The cell lysates containing intracellular bacteria were serially diluted
and spread on agar plates to enumerate bacterial CFUs.
Reagents
LPS (from E. coli serotype 055:B5) was purchased from Sigma-Aldrich.
Pam3Csk4, poly(I:C), and CpG-ODN were from InvivoGen. The inhibitors
SP600125, BAY-11-7082, SB20358, and U0126 were obtained from Biyuntian
Biotechnology, and SN-50 was from Merck Millipore. Antibodies specific for
p65 and p300 were obtained from Santa Cruz Biotechnology. Antibodies spe-
cific for ERK1/2 (Thr202/Tyr204), JNK1/2 (Thr183/Tyr185), p38 (Thr180/
Tyr182), and iNOS were purchased from Cell Signaling Technology. Anti-
PSME3 antibody was from Invitrogen. Anti-HA (hemagglutinin) and anti-Flag
antibodies were purchased from Sigma-Aldrich. Rabbit anti-KLF2 polyclonaland PSME3 siRNA were cotransfected into HeLa cells, and the half-life of KLF2
vels. BMDMswere stimulation with LPS, and the KLF2 protein was detected by
stability in BMDMs was assessed by the CHX chase assay.
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Figure 6. PSME3 Regulates Bactericidal Activities via KLF2
(A) PSME3 expression abrogates KLF2-mediated suppression of NF-kB reporter gene activity. KLF2 and PSME3 or PSME3 N151Y were cotransfected with a
NF-kB promoter reporter gene into 293T cells. The reporter gene activity was analyzed by dual-luciferase assay after stimulation with TNFa (10 ng/ml) for 3 hr.
*p < 0.05 (Student’s t test).
(B) PSME3 fails to impact bactericidal effects of macrophages in the absence of KLF2. PEMs were transfected with control siRNA or PSME3- and KLF2-specific
siRNA and incubated with E. coli at an MOI of 4. The bacterial killing activity was analyzed by APA. *p < 0.05; **p < 0.01; and ***p < 0.001 (Student’s t test).
(C) PSME3 fails to impact NO production in macrophages in the absence of KLF2. PEMs were transfected with control siRNA or PSME3- and KLF2-specific
siRNA and stimulated with LPS for 12 hr. Nitrite levels in the culture media were determined by the Griess assay. **p < 0.01 (Student’s t test).
(D–F) PSME3 fails to impact NF-kB target genes expression in macrophages in the absence of KLF2. PEMs were transfected with control siRNA or PSME3- and
KLF2-specific siRNA and stimulated with LPS for 6 hr. The mRNA levels of iNOS (D), IL-1b (E), and TNFa (F) were determined by quantitative real-time PCR.
*p < 0.05; **p < 0.01 (Student’s t test).
Error bars indicate mean ± SD.
See also Figure S6.antibody was generated by GL Biochem (Shanghai), using recombinant pro-
tein as the antigen.
Flow Cytometry
To assay bacterial uptake, GFP-labeled heat-inactive E. coli were added to
monolayers of RAW264.7 cells or BMDMs at an MOI of 8 and cocultured
with these cells for 2 hr at 37C, after which the cells were washed three times746 Cell Reports 14, 737–749, February 2, 2016 ª2016 The Authorsand treated with Trypan blue for 10 min to quench cell surface fluorescence.
The data were collected using a FACSCalibur flow cytometer (BD Biosciences)
and analyzed using FlowJo software.
Nitrite Determination
Conditioned cell culture media were collected after 12 hr of LPS treatment and
then incubated with Griess reagent (Biyuntian Biotechnology) in 96-well plates.
Figure 7. A Model for the Role of PSME3 in NF-kB Signaling
PSME3 regulates host defense against bacterial pathogens by regulating the stability of the transcription factor KLF2. After bacterial infection or TLR ligands
stimulation, PSME3, whose expression is upregulated via the NF-kB pathway, directly binds to and destabilizes KLF2, leading to augmented activation of NF-kB
signaling.The absorbance was measured at 540 nm using a microplate spectrophotom-
eter according to the manufacturer’s protocol.
Real-Time PCR
Total RNA was isolated from primary macrophages and RAW264.7 cells using
TRIzol reagent (Invitrogen) according to the manufacturer’s instructions and
subjected to reverse transcription with random hexanucleotide primers.
Real-time PCR was performed with Universal SYBR Green PCR Master Mix
and an Applied Biosystems StepOnePlus Real-Time PCR System using spe-
cific primers with the following sequences: TNFa forward, 50-GACCCTCA
CACTCAGATCAT-30; TNFa reverse, 50-TTGAAGAGAACCTGGGAGTA-30; IL-
1b (interleukin-1b) forward, 50-CAACCAACAAGTGATATTCTCCATG-30; IL-1b
reverse, 50-GATCCACACTCTCCAGCTGCA-30; iNOS forward, 50-CCTCCTC
CACCCTACCAAGT-30; iNOS reverse, 50-CACCCAAAGTGCTTCAGTCA-30;
CRAMP forward, 50-CTTCAACCAGCAGTCCCTAGACA-30; CRAMP reverse,
50-TCCAGGTCCAGGAGACGGTA-30; PSME3 forward, 50-TCCTCACCAA
TAGCCACG-30; and PSME3 reverse, 50-CTCGATCAGCAGCCGAAT-30.
ChIP Assay
PEMswere stimulated with or without LPS and then crosslinked with 1% form-
aldehyde at room temperature for 10 min. Nuclear extracts from the PEMs
were subjected to immunoprecipitation with anti-IgG (immunoglobulin G),
anti-p65, and anti-p300 antibodies and protein A/G beads at 4C overnight.
The precipitates were then washed and eluted, followed by heating at 65C
to reverse the formaldehyde crosslinking. The specific primers used in theCChIP assay were as follows: PSME3 forward, 50-GATAAGCCACGAG
GCTGTTTTG-30; PSME3 reverse, 50-GTCCCTCGGGCTAGTGTCAAAC-30;
iNOS forward, 50-CACCACAGAGTGATGTAATC-30; iNOS reverse 50- GTC
TTCAACTCCCTGTAAAG 30; IL1b forward 50- CTACCTTTGTTCCGCACA
TCC-30; IL1b reverse, 50- CCCTCCCTTGTTTTATAGTCC-30; TNFa forward,
50-GAAAACTCACTTGGGAGCAGG-30; TNFa reverse, 50- GTGCTTCTGAA
AGCTGGGTG-30; CRAMP forward, 50-CACTAAATCTAGGCTCACTCC-30;
and CRAMP reverse, 50-GCCTTGGCTTCTCCTGGGCCC-30.
Immunoprecipitation and Immunoblotting
Cells were treatedwith the proteasome inhibitorMG132 (20 mM; Sigma) for 4 hr
before harvesting, lysed in lysis buffer (50 mM Tris-HCl [pH 7.4], 150mMNaCl,
10% glycerol, 1 mM EDTA, and 0.5% Nonidet P-40) supplemented with a
mixture of protease inhibitors and cleared by centrifugation. The cleared cell
lysate was incubated with the indicated antibody and 15 ml of protein A/G
beads (Santa Cruz Biotechnology) for 3 hr at 4C. The immunoprecipitates
were washed at least three times in lysis buffer. These protein samples were
resolved by SDS-PAGE and transferred onto nitrocellulose membranes (Milli-
pore). The membranes were blocked with 5% nonfat milk and then incubated
with the indicated primary antibodies. The immunoblot bands were detected
using the Odyssey system (LI-COR Biosciences).
GST Pull-Down Assays
Bacteria-expressed glutathione S-transferase (GST) or GST-PSME3 pro-
teins were purified using Glutathione-Sepharose 4B beads (Amershamell Reports 14, 737–749, February 2, 2016 ª2016 The Authors 747
Biosciences) and then incubated with His-KLF2 for 1 hr at 4C. Bound KLF2
was detected by immunoblotting.
MS Experiment
H1299 cells were transfected with the plasmid for Flag-PSME3 expression.
Cells were treated with the proteasome inhibitor MG132 (20 mM; Sigma) for
6 hr before harvesting and were lysed in lysis buffer (50 mM Tris-HCl
[pH 7.4], 150 mM NaCl, 10% glycerol, 1 mM EDTA, and 0.5% Nonidet P-40)
supplemented with a mixture of protease inhibitors. After clearance by centri-
fugation, the cell lysate was incubated with the M2 anti-Flag beads (Sigma) for
3 hr at 4C. The immunoprecipitate was washed at least three times in lysis
buffer. The samples were then separated on the 10% SDS-PAGE gel and
stained with Coomassie blue. After extensive destaining, the gel was excised
into approximately 1-mmbands and digested with sequencing grademodified
trypsin (Promega). Peptides were extracted and analyzed using a liquid chro-
matography (LC) system (Dionex UltiMate 3000 Nano/Cap Pump, Thermo
Fisher Scientific) coupled with an electrospray ionization quadruple time-of-
flight (ESI-Q-TOF) mass spectrometer (Maxis Impact, Bruker Daltonik).
Statistical Analysis
Values are presented as the mean ± SD unless otherwise indicated. The sta-
tistical significance of differences between two groups was determined using
Student’s t test analysis. Survival data were analyzed by constructing Kaplan-
Meier plots using the log-rank test in Prism software. A difference with p < 0.05
was determined to be statistically significant.
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